<?xml version="1.0" encoding="UTF-8"?>
<p>The clinical features of COVID-19, as determined from 99 patients in Wuhan city, China are fever (83%), cough (82%), shortness of breath (31%), muscle pain (11%), confusion (9%), headache (8%), sore throat (5%), rhinorrhea (4%), chest pain (2%), diarrhea (2%), and nausea and vomiting (1%) [
 <xref rid="B4-ijerph-17-02225" ref-type="bibr">4</xref>]. A study revealed that reported patients tended to be older males who had the fatal condition of acute respiratory distress syndrome (ARDS) [
 <xref rid="B4-ijerph-17-02225" ref-type="bibr">4</xref>]. As of 28 February 2020, the day on which this perspective was finalized, a total of 46 countries other than China have reported to have 2019-nCoV cases (Source WHO Situation Report-38). According to the WHO situation report, globally, 179,000 thousand cases have been confirmed and the number is increasing every hour. Understanding the disease etiology, epidemics, genomics, clinical findings, and treatment options requires extensive data from sampling, laboratory work, and clinical trials [
 <xref rid="B5-ijerph-17-02225" ref-type="bibr">5</xref>,
 <xref rid="B6-ijerph-17-02225" ref-type="bibr">6</xref>]. Rapid findings can help to control the disease spread as well as further outbreaks of contagious viruses. COVID-2019 transmission occurs person-to-person, either through direct transmission by sneeze, cough, or droplet inhalation, or contact transmission such as ocular contact or through mucous membranes of the eyes and nose and saliva [
 <xref rid="B7-ijerph-17-02225" ref-type="bibr">7</xref>,
 <xref rid="B8-ijerph-17-02225" ref-type="bibr">8</xref>].
</p>
